Imaging During Surgery in Diagnosing Patients With Prostate, Bladder, or Kidney Cancer
Trial ID or NCT#
NCT01688414
Status
NOT RECRUITING
Purpose
This pilot clinical trial studies imaging during surgery in diagnosing patients with prostate, bladder, or kidney cancer. New diagnostic imaging procedures, may find prostate, bladder, or kidney cancer
Official Title
Utility of Fluorescence and Photoacoustic Imaging Intraoperatively to Assist With Robotic Assisted Minimally Invasive Surgery
Eligibility Criteria
Ages Eligible for Study: 18 Years to 85 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No
Inclusion Criteria:
- - Patients must have a pathologic confirmation of prostate cancer, bladder cancer, or kidney cancer based on previous biopsies or procedures OR a strong concern for a kidney malignancy based on computed tomography (CT) or magnetic resonance imaging (MRI) imaging - Ability to understand and the willingness to sign a written informed consent document
Exclusion Criteria:
- - Patients with a surgical history or anatomic variant that would preclude robot assisted laparoscopic approaches to their surgery (i.e. history of ventral hernia repair with mesh) - Patients with medical co-morbidities who cannot tolerate laparoscopic surgery secondary to intra-abdominal carbon dioxide insufflation - Patients with documented allergy or adverse drug reaction to indocyanine green or baseline serum creatinine greater than 1.5 mg/dL
Investigator(s)
Benjamin I. Chung
Urologic oncologist,
Urologic specialist,
Urologist,
Genitourinary specialist,
Urologic surgeon
Associate Professor of Urology
Sanjiv Sam Gambhir, MD, PhD
Harcharan Gill
Urologic oncologist,
Urologist,
Genitourinary specialist,
Urologic surgeon
Kathryn Simmons Stamey Professor, Emeritus
Contact us to find out if this trial is right for you.
Contact
Mark Gonzalgo
650-725-5544
View on ClinicalTrials.gov
